Skip to main content
Tech.euFundingExplorerBeta

TRIcares

A medical device company developing a catheter-based tricuspid valve replacement system for the treatment of severe tricuspid regurgitation.

TRIcares has raised €88M across 3 funding rounds from 1 investor, most recently a Debt round in Jan 2026. Based in Paris, France; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€88M
€88,078,702
Funding rounds
3
Investors
1
distinct backers
Active since
2018-02
latest 2026-01

Funding by year

EUR raised per year · 2026 YTD
TRIcares — funding by year — interactive chart.
Data table
TRIcares — funding by year
2018€22M
2024€46M
2026€20M

Signals

High confidence
Raise-next likelihood50
base rate 45% for Debt
  • ▲ In typical raise window
  • ▼ Down/flat last round
  • ▼ Low backer re-investment
Exit likelihood12
base rate 11% (2+ rounds)
  • ▲ €30M+ raised
  • ▲ 8y since founding (typical exit age)
  • ▼ No recent equity round (debt-only or quiet)

Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

3 rounds
DateStageAmountInvestors
2026-01-23Debt€20MEuropean Investment Bank (EIB)View deal →
2024-07-25Series D+€46M—View deal →
2018-02-01Series B€22M—View deal →

Similar companies

same sector or country

Global coverage: FundingData